Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1986;73:224-226

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hammon, J. W.
Right arrow Articles by Oates, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hammon, J. W.
Right arrow Articles by Oates, J. A.

Circulation, Vol 73, 224-226, Copyright © 1986 by American Heart Association


ARTICLES

Interaction of platelets with the vessel wall in the pathophysiology of sudden cardiac death

JW Hammon and JA Oates

The occurrence of ventricular fibrillation after occlusion of the circumflex coronary artery in the conscious dog was examined as one preparation for sudden cardiac death arising from coronary artery disease. The incidence of ventricular fibrillation after after circumflex occlusion was reduced from 53% to 6% (p less than .01) by the infusion of prostacyclin in doses that do not alter cardiac output or peripheral resistance. This effect of prostacyclin led to the evaluation of two structurally different inhibitors of thromboxane synthase in this preparation; RO 22-4679 and U-63557A reduced ventricular fibrillation by 82% and 100%, respectively (p less than .05). The inhibition of ventricular fibrillation by U-63557A was abrogated by pretreatment with indomethacin, suggesting that a metabolite of the endoperoxide that accumulated during thromboxane synthase inhibition was responsible for the protection from ventricular fibrillation.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Wang, V. V. Patel, E. Ricciotti, R. Zhou, M. D. Levin, E. Gao, Z. Yu, V. A. Ferrari, M. M. Lu, J. Xu, et al.
Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function
PNAS, May 5, 2009; 106(18): 7548 - 7552.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. H. Smith, M. S. Petrie, J. D. Morrow, J. A. Oates, and D. E. Vaughan
The sterol response element binding protein regulates cyclooxygenase-2 gene expression in endothelial cells
J. Lipid Res., May 1, 2005; 46(5): 862 - 871.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. H. Smith, O. Boutaud, M. Breyer, J. D. Morrow, J. A. Oates, and D. E. Vaughan
Cyclooxygenase-2-Dependent Prostacyclin Formation Is Regulated by Low Density Lipoprotein Cholesterol In Vitro
Arterioscler Thromb Vasc Biol, June 1, 2002; 22(6): 983 - 988.
[Abstract] [Full Text] [PDF]